Sign Up to like & get
recommendations!
1
Published in 2018 at "Movement Disorders"
DOI: 10.1002/mds.27465
Abstract: After 5 years of treatment with levodopa, approximately 40% to 50% of patients with Parkinson's disease (PD) develop motor complications such as dyskinesias or motor fluctuations. These are often accompanied by nonmotor fluctuations, such as…
read more here.
Keywords:
patients motor;
anxiety;
frequency;
motor fluctuations ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Neurology"
DOI: 10.1007/s00415-020-10366-9
Abstract: We aimed to determine (1) the test–retest reliability of a newly developed portable fixed dynamometer (PFD) as compared to the hand-held dynamometer (HHD) in patients with motor neuron disease (MND) and (2) the PFD’s ability…
read more here.
Keywords:
strength;
muscle strength;
patients motor;
pfd ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "International Journal of Neuroscience"
DOI: 10.1080/00207454.2016.1194274
Abstract: Background. Spirometry patterns suggesting restrictive and obstructive pulmonary dysfunction have been reported in Parkinson’s disease (PD). However, the patterns’ precise relation to PD pathophysiology remains unclear. Purpose/Aim. To assess ON- versus OFF-state pulmonary function, the…
read more here.
Keywords:
state;
patients motor;
spirometry;
pulmonary function ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2021.678373
Abstract: Background: Non-motor symptoms (NMS), including neuropsychiatric, sleep, autonomic, and sensory domains, are an integral aspect of the clinical presentation of Parkinson disease (PD) and affect neurocognitive functioning as well as patients' and caregivers' well-being. Objective:…
read more here.
Keywords:
patients motor;
parkinson;
non motor;
motor symptoms ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics13091395
Abstract: Parkinson’s disease (PD) is a progressive, neurodegenerative disorder primarily affecting dopaminergic neuronal systems, with impaired motor function as a consequence. The most effective treatment for PD remains the administration of oral levodopa (LD). Long-term LD…
read more here.
Keywords:
motor complications;
ropinirole patients;
patients treated;
patients motor ... See more keywords